The world's first male contraceptive injection is closer to being a reality after Indian researchers successfully completed their clinical trial.
According to the Hindustan Times, the Indian Council of Medical Research, a government-funded biomedical research agency, found its contraceptive had a 97.3 per cent success rate.
Users injected the contraceptive into their penis, and it is claimed no side effects were reported.
"The product is ready, with only regulatory approvals pending [from the government]," Dr RS Sharma, senior scientist with ICMR, told the local news outlet. "The trials are over, including extended, Phase 3 clinical trials for which 303 candidates were recruited with a 97.3 per cent success rate and no reported side effects. The product can safely be called the world's first male contraceptive."
The male birth control method is meant to last 13 years.